ARCHIVES

ODAC Votes 10-0 In Favor Of Avastin For Recurrent Glioblastoma Multiforme

This article is from The Cancer Letter archive.

Vol. 35 No. 13 | April 3, 2009

Download PDF Visit The Full Archive

Related Articles

Clinical Oncology Grant Funding: The History Of a Controversy

July 23, 1993

NCI Plans To Issue Frederick Operations Contract As Sole-Source To SAIC-Frederick Inc. For Up To 10 Years.

November 10, 2006

NCCS Networker Volume 9 Issue 4, Winter 1995

January 12, 1995

Avastin doubles progression-free survival in metastatic disease.

May 27, 2005

Continuing Resolution Averts Shutdown; Locks in Sequestration Cuts for NIH, NCI

March 22, 2013

Oncologists lose money administering drugs to Medicare patients, survey finds.

January 23, 2004